Scinovex
articleTop 1% cited

Review article: yeast as probiotics –<i>Saccharomyces boulardii</i>

Alimentary Pharmacology & Therapeutics · 2007 · Vol. 26(6) · pp. 767–778
Dorota CzeruckaT. PichePatrick Rampal

Abstract

Saccharomyces boulardii is a strain of yeast which has been extensively studied for its probiotic effects. The clinical activity of S. boulardii is especially relevant to antibiotic-associated diarrhoea and recurrent Clostridium difficile intestinal infections. Experimental studies clearly demonstrate that S. boulardii has specific probiotic properties, and recent data has opened the door for new therapeutic uses of this yeast as an 'immunobiotic'.

Probiotics and Fermented FoodsClostridium difficile and Clostridium perfringens researchGut microbiota and healthSaccharomyces boulardiiProbioticAntibiotic-associated diarrheaDiarrheaMedicineYeastMicrobiologySaccharomycesAntibioticsClostridium difficile

MeSH terms

Anti-Inflammatory AgentsAnti-Bacterial AgentsDiarrheaDouble-Blind MethodHumansSaccharomycesTreatment OutcomeProbiotics
Citations
562
FWCI
17.37
field-weighted impact
References
77
Percentile
100%
vs. same field & year
Citations per year
Cited by
Systematic review and meta-analysis of<i>Saccharomyces boulardii</i>in adult patients
World Journal of Gastroenterology · 2010 · 506 citations
References
Antibiotic resistance in food lactic acid bacteria—a review
International Journal of Food Microbiology · 2005 · 744 citations
Identification and antibiotic susceptibility of bacterial isolates from probiotic products
International Journal of Food Microbiology · 2003 · 492 citations
Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease
Digestive Diseases and Sciences · 2000 · 713 citations
Innate Immune Recognition
Annual Review of Immunology · 2002 · 8,305 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.